SensArs
Pre Seed Round in 2024
SensArs specializes in medical equipment manufacturing, focusing on neuromodulation solutions. Its flagship product, SENSY, is an innovative healthcare technology system designed to restore natural sensations to the feet for patients who have undergone amputations or suffer from nerve damage due to diabetic neuropathy.
Lys Therapeutics
Seed Round in 2022
Lys Therapeutics is a biotechnology company focused on developing therapies for patients with neurovascular and neurodegenerative disorders. The company is notable for its lead drug, Glunozumab, a monoclonal antibody that employs a novel mechanism of action. This drug hyperactivates both vascular and neuronal NMDA receptors, leading to off-target toxicity that can disrupt the blood-brain and blood-spinal cord barriers, resulting in neuronal excitotoxicity associated with conditions such as stroke and multiple sclerosis. Lys Therapeutics aims to address neuroinflammation and its effects on neurodegeneration through innovative biotherapies.
Leuko Labs, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in the development of healthcare equipment. The company's primary product, PointCheck, is a non-invasive device designed to monitor and count white blood cells. This innovative technology allows for more frequent testing of immunosuppressed patients, such as those undergoing chemotherapy, enhancing their quality of life and clinical outcomes. The device is particularly beneficial as it eliminates the need for invasive blood draws and laboratory infrastructure, making it more accessible and convenient for patients.
Neurofenix
Series A in 2022
Neurofenix is a company focused on enhancing rehabilitation for stroke victims through innovative technology. It has developed an upper limb rehabilitation device that aims to make therapy more autonomous, enjoyable, and accessible. This device features a hand-training controller that allows users to engage their impaired hand in interactive video games, transforming traditional rehabilitation exercises into fun and immersive experiences. By providing patients with effective arm and hand therapy both in clinical settings and from the comfort of their homes, Neurofenix seeks to empower stroke survivors in their recovery journeys.
Endostart
Series B in 2021
Endostart is a developer of innovative colonoscopy technologies aimed at improving the efficiency and safety of colonoscopy procedures. The company has created a proprietary Magnetic Balloon Anchoring Technology, which includes a magnetic balloon guide, a ferrofluid syringe, and a multi-use magnetic handpiece. These advancements are designed to assist healthcare professionals in guiding and navigating colonoscopy procedures, thereby reducing wall stress and minimizing the need for general anesthesia. Through its unique approach, Endostart seeks to enhance patient comfort and streamline the colonoscopy process.
Univercells
Series C in 2021
Univercells is a company specializing in high-density, low-cost biomanufacturing solutions aimed at enhancing the production of biologics, including antibodies, proteins, and vaccines. The company leverages innovative engineering and proprietary technologies, such as single-use systems and continuous process intensification, to significantly reduce capital investments by over 75% and the cost of goods by up to 90%. Univercells offers a range of services, including scale-X hydro, scale-X carbo, and NevoLine, which support both research and development and commercial-scale production of biologics. Additionally, the company provides integrated services like equipment confirmation, capacity and facility design, and bioprocess excellence, facilitating the scalability of cell and gene therapy manufacturers from clinical trials to commercial manufacturing. Through its commitment to making biologics more accessible and affordable, Univercells addresses critical global health challenges.
AirGo develops non-invasive medical respiratory sensors designed for real-time minute ventilation and breath dynamics monitoring. The device is wearable and measures live circumference changes, enabling long-term live and remote patient monitoring during daily activities, sleep sessions, and exercise. It processes data in real-time, outputting live alarms and comprehensive diagnostic reports for physicians, aiding faster diagnosis with added precision.